A number of other research analysts have also recently weighed in on IPHS. TheStreet cut Innophos from a b- rating to a c+ rating in a research report on Thursday, May 23rd. Zacks Investment Research cut Innophos from a hold rating to a sell rating in a report on Friday, August 9th. Three analysts have rated the stock with a sell rating and one has issued a buy rating to the company. Innophos presently has an average rating of Hold and a consensus target price of $31.00.
IPHS stock opened at $26.49 on Thursday. Innophos has a twelve month low of $22.57 and a twelve month high of $46.65. The company has a quick ratio of 1.41, a current ratio of 2.85 and a debt-to-equity ratio of 0.97. The stock has a market cap of $512.56 million, a P/E ratio of 11.62 and a beta of 1.43. The business’s 50-day moving average price is $27.54 and its 200-day moving average price is $29.75.
The firm also recently declared a quarterly dividend, which will be paid on Friday, September 6th. Investors of record on Friday, August 23rd will be issued a $0.48 dividend. The ex-dividend date of this dividend is Thursday, August 22nd. This represents a $1.92 dividend on an annualized basis and a yield of 7.25%. Innophos’s dividend payout ratio is presently 84.21%.
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Geode Capital Management LLC increased its holdings in Innophos by 5.8% in the 4th quarter. Geode Capital Management LLC now owns 223,850 shares of the specialty chemicals company’s stock valued at $5,490,000 after buying an additional 12,229 shares during the period. Metropolitan Life Insurance Co. NY boosted its stake in shares of Innophos by 353.5% in the 4th quarter. Metropolitan Life Insurance Co. NY now owns 6,403 shares of the specialty chemicals company’s stock valued at $157,000 after purchasing an additional 4,991 shares in the last quarter. Millennium Management LLC boosted its stake in shares of Innophos by 553.7% in the 4th quarter. Millennium Management LLC now owns 69,597 shares of the specialty chemicals company’s stock valued at $1,707,000 after purchasing an additional 58,950 shares in the last quarter. Public Employees Retirement System of Ohio boosted its stake in shares of Innophos by 14.1% in the 4th quarter. Public Employees Retirement System of Ohio now owns 2,708 shares of the specialty chemicals company’s stock valued at $66,000 after purchasing an additional 334 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in shares of Innophos by 3.7% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,084,227 shares of the specialty chemicals company’s stock valued at $26,596,000 after purchasing an additional 38,309 shares in the last quarter. 93.26% of the stock is currently owned by institutional investors.
Innophos Company Profile
Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste.
Featured Story: What is Call Option Volume?
Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.